Completed PHASE3 INTERVENTIONAL 2-arm NCT03033121

Three-times-weekly Versus Daily Growth Hormone (GH) Treatment in naïve GH-deficient Children (GH 3 wk dose)

More Favorable Metabolic Impact of Three-times-weekly Versus Daily Growth Hormone (GH) Treatment in naïve GH-deficient Children

Sponsor: University of Palermo

Conditions Growth Hormone Treatment

Interventions Growth Hormone

Updated 5 times since 2017 Last updated: Oct 25, 2017 Started: Jan 1, 2016 Primary completion: Jan 1, 2017 Completion: Jan 1, 2017

This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

A PHASE3 clinical study on Growth Hormone Treatment, this trial is completed. The trial is conducted by University of Palermo and has accumulated 5 data snapshots since 2016. Longitudinal tracking of this trial contributes to a broader understanding of treatment development timelines.

Status Flow

Change History

5 versions recorded

Sep 2024 — Present [monthly]

Completed PHASE3
Jul 2024 — Sep 2024 [monthly]

Completed PHASE3
Jan 2021 — Jul 2024 [monthly]

Completed PHASE3
Jun 2018 — Jan 2021 [monthly]

Completed PHASE3
Feb 2017 — Jun 2018 [monthly]

Completed PHASE3

First recorded

Jan 2016

Trial started

Per CT.gov start date — pre-dates our first snapshot

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:

University of Palermo

Data source: University of Palermo

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations

• Palermo, Italy